Director Bailey Reports a Million-Dollar BHVN Buy

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider transaction on today’s list is a Form 4 filing by Biohaven Pharmaceutical Holding Company Ltd $BHVN director Gregory Bailey.

Bailey bought 25,503 BHVN shares, equivalent to $999,169.

Here’s The Hot Corner, with data through April 25, 2024:

Fairmount Funds Management filed a 13D for Spyre Therapeutics $SYRE revealing an increase in ownership from 3.25% to 11.17%.

Have a great weekend. We’ll be back on Monday with more insider activity.

Sign up for The Hot Corner to have these insider transactions e-mailed to you every Monday through Friday.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

The post Director Bailey Reports a Million-Dollar BHVN Buy appeared first on All Star Charts.